Liu LL, Li F, Pao W, Michor F. 2015. Dose-Dependent Mutation Rates Determine Optimum Erlotinib Dosing Strategies for EGFR Mutant Non-Small Cell Lung Cancer Patients. PloS one. 10(11):e0141665. Pubmed: 26536620 DOI:10.1371/journal.pone.0141665



Related Faculty

Photo of Franziska Michor

Franziska Michor uses the tools of theoretical evolutionary biology, applied mathematics, statistics, and computational biology to address important questions in cancer research.

Search Menu